You have 9 free searches left this month | for more free features.

TS-134, multiple dose, titration

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Adult Subjects Trial in Toshima-ku (TS-172, Placebo)

Completed
  • Healthy Adult Subjects
  • Toshima-ku, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Apr 11, 2022

Healthy Volunteer Trial in Shinjuku-ku (TAK-935, Placebo)

Completed
  • Healthy Volunteer
  • Shinjuku-ku, Tokyo, Japan
    Clinical Research Hospital Tokyo
Nov 10, 2021

Overweight, Obesity Trial (LY3502970, Placebo)

Not yet recruiting
  • Overweight
  • Obesity
  • (no location specified)
Aug 29, 2023

Healthy Trial (BI 456906, Microgynon®)

Not yet recruiting
  • Healthy
  • (no location specified)
Jun 14, 2023

Progressive Multiple Sclerosis Trial in Lille, Strasbourg (Placebo, Masitinib (4.5))

Recruiting
  • Progressive Multiple Sclerosis
  • Placebo
  • Masitinib (4.5)
  • Lille, France
  • +1 more
Jul 1, 2022

Overweight, Obesity Trial in San Antonio, Salt Lake City (LY3305677, Placebo)

Recruiting
  • Overweight
  • Obesity
  • San Antonio, Texas
  • +1 more
Jan 3, 2023

Healthy Trial (Ketamine, Ts-134, Placebo)

Recruiting
  • Healthy
  • New York, New York
    NYSPI
Jan 3, 2023

Healthy, Obesity Trial (BI 1820237, semaglutide, Placebo)

Not yet recruiting
  • Healthy
  • Obesity
  • BI 1820237
  • +3 more
  • (no location specified)
Mar 6, 2023

Obesity Trial in Mainz, Neuss (BI 456906, Placebo)

Completed
  • Obesity
  • BI 456906
  • Placebo
  • Mainz, Germany
  • +1 more
Mar 18, 2021

Healthy Volunteers Trial in Glendale (TS-134, Placebo)

Completed
  • Healthy Volunteers
  • Glendale, California
    PAREXEL - Early Phase Clinical Unit-Los Angeles
Nov 14, 2018

Atopic Dermatitis, Psoriasis, Asthma Trial in United Kingdom (EDP1867, Placebo)

Completed
  • Atopic Dermatitis
  • +2 more
  • Manchester, Greater Manchester, United Kingdom
  • +6 more
Oct 6, 2022

Diabetes, Type 2 Trial in Cheng Du, Beijing (Tirzepatide, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Cheng Du, Sichuan, China
  • +1 more
Aug 23, 2021

Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome Trial in China (YPEG-rhGH, rhGH)

Active, not recruiting
  • Idiopathic Short Stature
  • +2 more
  • Hefei, Anhui, China
  • +18 more
Apr 27, 2023

Healthy Volunteers Trial in Glendale (TS-161, TS-161 Placebo)

Completed
  • Healthy Volunteers
  • Glendale, California
    PAREXEL - Early Phase Clinical Unit-Los Angeles
Feb 26, 2020

Psoriasis, Atopic Dermatitis Trial in United Kingdom (EDP1066, Placebo oral capsule)

Completed
  • Psoriasis
  • Atopic Dermatitis
  • EDP1066
  • Placebo oral capsule
  • Guildford, Surrey, United Kingdom
  • +6 more
Nov 8, 2021

Diabetes Type 2 - Insulin-Treated Trial in Pittsburgh (Smartphone application and web portal, Standard Insulin Therapy

Active, not recruiting
  • Diabetes Mellitus Type 2 - Insulin-Treated
  • Smartphone application and web portal
  • Standard Insulin Therapy Education
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Jan 6, 2023

Multiple Sclerosis, Transcranial Direct Current Stimulation Trial in Istanbul (Transcutaneous Spinal Direct Current Stimulation)

Recruiting
  • Multiple Sclerosis
  • Transcranial Direct Current Stimulation
  • Transcutaneous Spinal Direct Current Stimulation
  • Istanbul, Kadıköy, Turkey
    Cadde Tıp Merkezi
Oct 31, 2023

Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)

Completed
  • Healthy Subjects
  • +2 more
  • HEC88473 injection
  • Placebo
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jul 14, 2023

Chronic Kidney Disease Trial in Multiple Locations (TS-143)

Completed
  • Chronic Kidney Disease
  • Multiple Locations, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Oct 4, 2022

Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers Trial in Overland Park (TMP-301, Placebo)

Active, not recruiting
  • Cocaine Use Disorder
  • +2 more
  • Overland Park, Kansas
    Altasciences
Aug 29, 2023

Tourette Syndrome Trial in Worldwide (TEV-50717, Placebo)

Terminated
  • Tourette Syndrome
  • Dothan, Alabama
  • +75 more
Nov 5, 2021

Candidiasis, Chronic Mucocutaneous Trial run by the Matinas BioPharma Nanotechnologies, Inc. (Amphotericin B)

Completed
  • Candidiasis, Chronic Mucocutaneous
  • Amphotericin B
  • Bethesda, Maryland
    National Institute of Allergy and Infectious Disease (NIAID)
Aug 17, 2022

Diabetic Macular Edema Trial in Beijing (ASKG712)

Not yet recruiting
  • Diabetic Macular Edema
  • ASKG712
  • Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Jul 12, 2023

Healthy Male Subjects Trial in Tokyo ([14C] TS-142)

Completed
  • Healthy Male Subjects
  • [14C] TS-142
  • Tokyo, Japan
    Taisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022

Phenylketonurias Trial in Aurora (RTX-134)

Active, not recruiting
  • Phenylketonurias
  • Aurora, Colorado
    Children's Hospital Colorado
Jan 6, 2022